jaguar.health (JAGX) - Revenue and Sales Volume

The sales revenue chart for Jaguar Health, Inc. (JAGX) reflects the asset's dynamics, where the current value is 0.03. Jaguar Health, Inc. (JAGX) dominates the plant-based gastrointestinal segment due to the patent protection of crofelomer against generics. The R&D center is currently conducting final tests on an oncology drug. Expansion of Mytesi in Europe and entry into the veterinary market will drive growth.
Analytical breakdowns for Jaguar Health, Inc.

The commercial expansion of Mytesi and the broadening of insurance coverage in the US define the current scale of Jaguar Health, Inc. (JAGX) operations. By analyzing a series of company sales data, investors assess the daily aggregate revenue, which allows them to verify the speed of business recovery following shocks and confirm the stability of asset market value through actual cash flow.